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Abstract The inhibitory control of actions has been
claimed to rely on dopaminergic pathways. Given that this
hypothesis is mainly based on patient and drug studies,
some authors have questioned its validity and suggested
that beneWcial eVects of dopaminergic stimulants on
response inhibition may be limited to cases of suboptimal
inhibitory functioning. We present evidence that, in care-
fully selected healthy adults, spontaneous eyeblink rate, a
marker of central dopaminergic functioning, reliably pre-
dicts the eYciency in inhibiting unwanted action tendencies
in a stop-signal task. These Wndings support the assumption
of a modulatory role for dopamine in inhibitory action con-
trol.
Keywords Response inhibition · Dopamine · 
Spontaneous eyeblink
Introduction
The ability to stop ongoing actions is an important charac-
teristic of cognitive control and Xexibility (Logan 1994).
Increasing evidence suggests that it emerges mainly from
interactions between the prefrontal cortex (PFC) and the
basal ganglia (Aron et al. 2003; Miller and Cohen 2001;
van den Wildenberg et al. 2006). For instance, functional
imaging studies have indicated the involvement of the PFC
in response inhibition by comparing trials on which sub-
jects executed a speeded response to ‘‘go’’ signals with tri-
als on which subjects were required to withhold their
response upon a ‘‘no-go’’ (Garavan et al. 1999; Kelly et al.
2004;) or a ‘‘stop’’ signal (Rubia et al. 2001, 2003). In the
standard stop-signal task (Logan and Cowan 1984), partici-
pants are Wrst presented with a stimulus telling them to exe-
cute a particular response, which may or may not be
followed by a stop-signal calling for the immediate abor-
tion of that response. Versions of this task have been used
to investigate the eYciency to stop various sorts of cogni-
tive processes and so performance on it can be considered
to diagnose the individual eYciency of actively inhibiting
one’s “thoughts and actions” (Logan 1994; Logan and
Cowan 1984).
Stop-signal tasks provide a direct behavioral assessment
of the ability to stop a planned or an ongoing motor
response in a voluntary fashion and an estimate of the
duration of the covert response-inhibition process (i.e., the
stop-signal reaction time or SSRT; see Fig. 1). Using this
dependent measure of stop performance has provided addi-
tional evidence for the involvement of the PFC in response
inhibition. A recent study of SSRT obtained from patients
with lesions in the PFC indicated that the degree of damage
within the right inferior frontal gyrus, more than other
regions within the PFC, is critically related to impaired
response inhibition (Aron et al. 2003). Rieger et al. (2003)
examined stop-task performance of patients with frontal
lesions, patients with lesions outside the frontal cortex,
patients with lesions in the basal ganglia, and orthopedic
controls. Relative to controls, only patients with right
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inhibitory deWcits. These results provide evidence not only
for a role of the frontal lobes, but also of the basal ganglia
in the inhibition of ongoing responses.
In recent years, central serotonin (5-HT) function has
been thought to be a critical component of behavioral inhi-
bition and impulse control (Eagle et al. 2007; Evenden
1999; Linnoila et al. 1983; Robbins 2007). However, in
recent clinical studies, 5-HT manipulations failed to aVect
SSRT, measured by the stop-signal task. Neither 5-HT
depletion nor treatment with citalopram, a selective 5-HT
reuptake inhibitor (SSRI), signiWcantly aVected SSRT in
healthy human volunteers (Chamberlain et al. 2006; Clark
et al. 2005). Furthermore, the absence of an eVect of citalo-
pram on SSRT was reproduced in rats (Eagle et al. 2008),
showing that the failure of 5-HT to inXuence this form of
inhibition translates consistently across species.
It is unlikely that any single neuromodulatory mecha-
nism can explain the plethora of experimental factors that
are known to modulate behavioral inhibition. However,
dopamine (DA) represents a particularly likely candidate,
given the recent pattern of results reported by Eagle et al.
(2009). The authors tested the eVect of central 5-HT deple-
tion in rats on two aspects of behavioral inhibition, SSRT
and ‘waiting’, using the stop-signal task. 5-HT depletion
had no eVects on SSRT or any other primary measure of the
stop-signal task. However, within the same task, there was
a deWcit in ‘waiting’ in 5-HT-depleted rats when they were
required to withhold from responding in the terminal
element of the stop-signal task for an extended period.
Interestingly, D-amphetamine had dose-dependent, but not
5-HT-dependent eVects on SSRT. Conversely, the dose that
decreased SSRT (0.3 mg/kg) impaired the ability to wait,
again independently of 5-HT manipulation. These Wndings
suggest that SSRT and “waiting” are distinct measures of
behavioral inhibition, and that 5-HT may be critical for the
“waiting” component, while dopamine may be crucial for
SSRT.
Along these lines, Enticott et al. (2008) in contrast to
Badcock et al. (2002), found that schizophrenia patients
who suVer from dopaminergic imbalance in the basal gan-
glia inhibit responses more slowly than control subjects.
Another study showed response inhibition deWcits only
among the undiVerentiated, but not the paranoid, early-
onset schizophrenia patients (Bellgrove et al. 2006). More-
over, a study with Parkinson’s patients, who suVer from
loss of dopaminergic neurons in the basal ganglia, showed
longer SSRT (Gauggel et al. 2004) and impaired suppres-
sion of conXicting responses (Wylie et al. 2009) compared
to matched controls.
Unfortunately, these studies have major confounds given
that the schizophrenia and Parkinson’s patients were taking
antipsychotic drugs and L-DOPA, respectively, (which both
act on the dopaminergic system). The results obtained in
these studies may, thus, have mainly measured eVects of
medication use. Ideally, patient studies should test patients
“on” and “oV” medication, but for obvious ethical issues
these kinds of studies are diYcult to perform.
Very recently, Colzato et al. (2007a) observed that recre-
ational users of cocaine, who are likely to suVer from
reduced Dopamine D2 receptors in the striatum (Volkow
et al. 1999), needed signiWcantly more time to inhibit
responses to stop signals than non users. The Wndings of
these studies converge on the notion that the basal ganglia
play a critical role in the suppression of responses that are
incorrect or no longer relevant, and Wt with the assumption
that dopamine, which innervates these circuits, may play a
role in modulating response inhibition (see Mink 1996 for a
review). Note, however, that assessing the exact causal
relation between inhibitory control functions and cocaine is
complicated by the possibility of pre-existent neuro-devel-
opmental factors. Recent evidence showed that monkeys
having preexisting lowered D2 receptor densities demon-
strate higher risks to use cocaine and to become addicted
(Nader et al. 2006), and that chronic users may suVer preex-
isting problems in inhibitory control (Bechara 2005).
Purpose of this study
The present experiment was motivated by the suggestion
that dopamine may play a crucial role in response inhibition
(Mink 1996). Given that this hypothesis is mainly based on
patient and drug studies, some authors have questioned its
validity and suggested that beneWcial eVects of dopaminer-
gic stimulants on response inhibition may be limited to
subjects whose inhibitory eYciency is suboptimal (e.g., De
Fig. 1 Calculation of stop-signal RT (SSRT) according to a race mod-
el (Logan 1994; Logan and Cowan 1984). The curve depicts the distri-
bution of RTs on go trials (trials without a stop signal) representing the
Wnishing times of the response processes. Assuming independence of
go and stop processes, the Wnishing time of the stop process bisects the
go RT distribution. Given that the button-press response could be with-
held in 50% of all stop trials, stop-signal RT (200 ms) is calculated by
subtracting the mean stop-signal delay (100 ms) from the median go
RT (300 ms)123
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interested to test whether a dopaminergic impact on
response inhibition eYciency could be demonstrated in
healthy subjects.
Our measure of DA functioning was the spontaneous
eyeblink rate (EBR), a well-established clinical indicator
(Shukla 1985) thought to index dopamine production in the
striatum (Blin et al. 1990; Karson 1983; Taylor et al. 1999).
The idea that EBR reXects dopaminergic functioning is Wrst
of all supported by clinical observations in patients with
DA-related dysfunctions. For example, EBRs are elevated
in schizophrenia patients (Freed 1980), who in PET studies
demonstrate elevated striatal dopamine uptake, both, on
and oV medication (Hietala et al. 1999; Lindström et al.
1999) but EBRs are reduced in recreational cocaine users
(Colzato et al. 2008c), and in Parkinson’s patients
(Deuschel and Goddemeier 1998), two populations suVer-
ing from reduced functioning of D2 receptors and severe
losses of nigrostriatal dopaminergic cells, respectively
(Dauer and Przedborski 2003; Volkow et al. 1999). Repeti-
tive behavior disorders, related to lower levels of plasma
concentrations of the dopamine metabolite homovanillic
acid (HVA) (Lewis et al. 1996), are associated as well with
lower EBR rate (BodWsh et al. 1995; MacLean et al. 1985).
Very recently Colzato et al. (2009a) showed that the level
of psychoticism, which has been associated with dopami-
nergic activity (Gray et al. 1994), was predicted by EBR:
people with higher scores on the psychoticism scale
showed higher EBRs.
Second, pharmacological studies in nonhuman primates
and humans have shown that DA agonists, as apomorphine,
and antagonists increase and decrease EBRs, respectively
(Blin et al. 1990; Kleven and Koek 1996). Third, a genetic
study in humans demonstrated a strong association between
EBR and the DRD4/7 genotype, which is related to the con-
trol of striatal DA release (Dreisbach et al. 2005).
Further, albeit more indirect, evidence for the idea that
EBR reXects dopaminergic activity comes from studies
showing that EBR reliably predicts behavioral performance
on cognitive tasks that have been associated with dopami-
nergic functioning (e.g., Dreisbach et al. 2005; Colzato
et al. 2007b, 2008b, 2009b). Taken altogether, the available
evidence suggests that EBR provides a reliable measure of
dopaminergic functioning.1
To ascertain that our subjects were in good mental
health, we selected them with the Mini International Neuro-
psychiatric Interview (MINI; Lecrubier et al. 1997a, b), a
well-established brief diagnostic tool in the clinical and
stress literature (Sheehan et al. 1998; Elzinga et al. 2007,
2008) that screens for several psychiatric disorders includ-
ing, among others, schizophrenia, depression, mania,
ADHD, and obsessive compulsive disorder.
Even though such a screening procedure is (unfortu-
nately) rather uncommon in research on inhibitory control,
it is important because preexisting psychiatric disorders
(such as schizophrenia, ADHD, and obsessive compulsive
disorder) are known to aVect response inhibition (Rosenberg
et al. 1997; Schachar and Logan 1990; Thoma et al. 2007).
Also of relevance was the age of participants, which we
therefore considered in our analyses: while inhibitory con-
trol is apparently unrelated to general intelligence (Logan
1994), inhibitory eYciency seems to decline at later stages
of the life span (Williams et al. 1999).
Finally, to assess response-inhibition functioning, we
employed a standard version of the stop-signal task, in
which participants responded to the direction of a green
arrow by pressing a button with the left or right index
Wnger. The stop signal was a sudden and unpredictable
color change of the arrow to red, signaling a deliberate
eVort to refrain from responding. As pointed out above, we
considered SSRT to indicate the eYciency of inhibitory
control, with longer SSRT pointing to less eYcient inhibi-
tory processing.
The hypothesis that dopaminergic pathways are crucial
in driving inhibitory control clearly predicts a relationship
between individual dopaminergic functioning and inhibi-
tory eYciency, which in our design translates into the pre-
diction of a correlation between EBR and SSRT. Which
direction this correlation should have is however more diY-
cult to predict. The perhaps more obvious expectation is
that of a negative sign, that is, more availability of dopa-
mine (associated with higher EBR) should improve inhibi-
tory processes and thus reduce SSRT. However, the
interactions between striatal dopamine supplies and cogni-
tive control functions are complicated.
According to the model proposed by Frank et al. (2007),
the basal ganglia support adaptive decision-making by
modulating the selection of frontal cortical action plans. In
short, two main neuronal populations in the striatum have
opposing eVects on action selection via output projections
through the globus pallidus, thalamus, and back to the
cortex. Activity in “Go” neurons facilitates the execution of
a cortical response, whereas “NoGo” activity suppresses
competing responses. Dopamine bursts and dips that occur
during positive and negative outcomes drive Go learning
(via D1 receptors) to seek rewarding actions, and NoGo
learning (via D2 receptors) to avoid actions that are
1 Even if it is not possible to completely exclude that EBR correlates
with functioning of other neurotransmitters, several patients, animal
and drugs studies showed that the “spontaneous” eyeblink rate seems
to be modulated by the dopaminergic system while the “conditioned”
eyeblink produced by acoustic startle seems to be driven by the seroto-
nergic system. Graham et al. (2002) found that Ketanserin, a serotonin
(5-HT) receptor antagonist drug, signiWcantly suppressed prepulse
inhibition of the eye response while haloperidol, a D2 dopamine recep-
tor blocking antipsychotic drug, had no eVect on prepulse inhibition.123
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thalamic nucleus (STN) provides a self-adaptive dynamic
control signal that temporarily prevents the execution of
any response, depending on decision conXict. According to
this model more dopamine than optimal (as associated with
higher EBR) decreases activity in the indirect pathway
(NoGo), a process that would enhance the competition
between responses. As a consequence of this enhanced com-
petition, we would expect longer SSRT, leading to a posi-
tive correlation. In any case, however, it is clear that some
correlation between EBR and SSRT should be obtained if
dopamine is really involved in inhibitory control.
Method
Participants
Twenty-seven young healthy adults (20 women and 7 men,
mean age = 23.5 SD = 3.7) served as subjects for partial
fulWllment of course credit or a Wnancial reward. Partici-
pants were recruited via ads posted on community bulletin
boards and by word of mouth. Following Colzato et al.
(2007a, b, 2008a, b, c) subjects were selected with the
MINI (Lecrubier et al. 1997a, b). The following exclusion
criteria were applied: no Axis 1 psychiatric disorder (DSM-
IV), including ‘substance abuse’; no clinically signiWcant
medical disease; no use of medication. Written informed
consent was obtained from all subjects; the protocol was
approved by the local ethical committee (Leiden Univer-
sity, Institute for Psychological Research). All participants
served in two sessions (held on the same day), one for
recording EBRs and the other for conducting the stop-sig-
nal task.
Apparatus and stimuli
The experiment was controlled by a ACPI uniprocessor PC
running on an Intel Celeron 2.8-GHz processor, attached to
a Philips 109B6 17 in., LightFrame 3, 96 dpi with refresh-
rate van 120-Hz monitor. Responses were made by pressing
the “Z” or “?” of the QWERTY computer keyboard with
the left and right index Wnger, respectively. Participants
were required to react quickly and accurately by pressing
the left and right key in response to the direction of a left-
or right-pointing green arrow (go trials) of about
3.5 £ 2.0 cm with the corresponding index Wnger.
EBR measurement
A BioSemi ActiveTwo system (BioSemi Inc., Amsterdam,
The Netherlands) was used to record the EBR. Following
Colzato et al. (2007a, b), eye movements were recorded,
with two vertical (one upper, one lower) and two horizontal
(one left, one right) Ag–AgCl electrodes, for 6-min eyes-
open segments under resting conditions. The vertical elec-
trooculogram (EOG), which recorded the voltage diVerence
between two electrodes placed above and below the left
eye, was used to detect eye blinks. The horizontal EOG,
which recorded the voltage diVerence between electrodes
placed lateral to the external canthi, was used to measure
horizontal eye movements. Given that spontaneous EBR is
supposed to be stable during daytime but increases in the
evening (8:30 p.m., as reported by Barbato et al. 2000),
data were never collected after 5 p.m. Additionally, we
asked participants to avoid alcohol and nicotine consump-
tion and to sleep suYciently the day before the recording.
Participants were comfortably seated in front of a blank
poster with a cross in the center, located about 1 m from the
participant. The participants were alone in the room and
asked to look at the cross in a relaxed state and to not move
their head or activate their facial muscles (factors known to
produce artifact in EOG recordings).
Stop-signal task
The experiment consisted of a 30-min session in which par-
ticipants completed a version of the task adopted from van
den Wildenberg et al. (2006). Arrows were presented pseu-
dorandomly, with the constraint that they signaled left- and
right-hand responses equally often. Arrow presentation was
response-terminated. Intervals between subsequent go sig-
nals varied randomly, but equiprobably, from 1,250 to
1,750 ms in steps of 125 ms. During these interstimulus
intervals, a white Wxation point (3 mm in diameter) was
presented. The green arrow changed to red on 30% of the
trials, upon which the choice response had to be aborted
(stop trials). A staircase-tracking procedure dynamically
adjusted the delay between the onset of the go signal and
the onset of the stop signal to control inhibition probability
(Levitt 1971). After a successfully inhibited stop trial, stop-
signal delay in the next stop trial increased by 50 ms,
whereas the stop-signal delay decreased by 50 ms in the
next stop trial when the participant was unable to stop. This
algorithm ensured that motor actions were successfully
inhibited in about half of the stop trials, which yielded
accurate estimates of SSRT (Band et al. 2003; see Fig. 1). It
compensated for diVerences in choice RT between partici-
pants. The stop task consisted of Wve blocks of 104 trials
each, the Wrst of which served as a practice block to obtain
stable performance.
Statistical analysis
Median RT to go signals and SSRT on to stop signals
were individually assessed to index response execution123
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hypothesis that dopamine modulates response inhibition,
we ran a Pearsons’s correlation test, which examined the
association between EBR and the individually calculated
SSRT. We also explored the relationship between EBR
and response execution. Given recent studies showing
gender diVerences for EBR and for SSRT (Dreisbach
et al. 2005; Li et al. 2006; Müller et al. 2007; Mulvihill
et al. 1997), independent samples t tests were performed
for analysis of EBR and SSRT diVerences between men
and women. A signiWcance level of P < 0.05 was adopted
for all statistical tests.
Results
EBRs
Data were examined using Brain Vision Analyzer (Brain
Products™ GmbH, Munich, Germany). We deWned an
eyeblink as a voltage change of 100 uv in a time interval
of 500 ms. Our sample of subjects had EBRs ranging
from 3.8 to 31.4 per min (mean = 14.0, SD = 7.9), which
according to our assumptions should represent a
suYciently wide range of tonic dopaminergic function-
ing.
Stop-signal task
Median RT to go signals (372 ms, SD = 26 ms) and SSRT
to stop signals (209 ms, SD = 30 ms) were individually
assessed to index response execution and response inhibi-
tion, respectively. Overall, participants were able to stop
their responses on stop-signal trials successfully in about
half of the time a stop signal instructed them to do so (51%,
SD = 2.9%), indicating that the dynamic tracking algorithm
worked. The percentage of choice errors to go signals was
low (1.3%, SD = 1.4).
To test whether response inhibition was modulated by
the dopaminergic system, we computed Pearson correla-
tion coeYcients to indicate the relationships between the
individually calculated EBR, SSRT, and age (a factor
known to inXuence stop-signal inhibition). As expected,
spontaneous EBR correlated (positively) with SSRT,
r(27) = 0.587, P < 0.001, but not with age, r(27) =
¡0.010, P = 0.96, indicating that age cannot account for
our observations. As Fig. 2 shows, increased EBR is asso-
ciated with prolonged SSRT. There was no relation
between EBR and go RT indexing response execution,
r(18) = ¡0.040, P = 0.84.
Sex diVerences No signiWcant sex diVerences were
obtained for EBR, t = 1.13, P = 0.26, and SSRT, t = 0.99,
P = 0.32.
Conclusions
Our Wndings show that in healthy people the spontaneous
EBR reliably predicts the eYciency in inhibiting action ten-
dencies in a stop-signal task. As participants were screened
for several psychiatric disorders in the current study, we
can rule out an account in terms of preexisting psychiatric
disorders (as schizophrenia, ADHD, and obsessive compul-
sive disorder) that have been associated with dopaminergic
abnormalities (Davis et al. 1991; Tripp and Wickens 2007;
Pooley et al. 2007). Given that our female and male partici-
pants did not signiWcantly diVer in EBR and SSRT mea-
surements, we doubt that our results can be attributed to sex
diVerences.
Even though the correlative nature of our Wndings does
not directly speak to the underlying causal relations, the
observed pattern does Wt with previous demonstration that
schizophrenia patients (Enticott et al. 2008), Parkinson’s
patients (van den Wildenberg et al. 2006; Gauggel et al.
2004) and recreational cocaine users (Colzato et al. 2007a,
b)—populations suVering from dopaminergic imbalance in
the basal ganglia—have more trouble inhibiting their
actions in response to stop signals. Taken together, these
observations support Mink’s (1996) hypothesis that dopa-
mine plays a crucial role in inhibitory control not only in
populations with suboptimal inhibitory eYciency (De Wit
et al. 2002; Scheres et al. 2003) but in healthy people as
Fig. 2 Scatter diagram of individual spontaneous eyeblink rate (EBR)
against SSRT (in ms)123
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our marker of striatal dopamine supply (EBR) and inhibi-
tory control (SSRT) is consistent with Frank et al.’s model
(2007) that more dopamine than optimal (associated with
higher EBR) decreases synaptic plasticity in the indirect
pathway, thus producing longer SSRT.
This leaves the question of how dopamine might modu-
late inhibitory control and why Parkinson’s patients and
cocaine users, who have reduced dopamine function, also
show longer SSRT (Gauggel et al. 2004; Colzato et al.
2007a, b). Even though the available evidence may be
taken to point to a linear relationship between response
inhibition and dopamine level, it may be as for other cog-
nitive function as working memory (Goldman-Rakic et al.
2000), that the relationship between response inhibition
and dopamine level may actually follow an inverted U-
shaped function. According to this idea, it is an average
dopamine level that allows for optimal cognitive perfor-
mance, whereas too high or too low levels impair cogni-
tive processes. The assumption of an inverted U-shaped
performance function of individual dopamine levels is
also consistent with a recent observation of Akbari
Chermahini and Hommel (2009), who studied the rela-
tionship between creativity and dopamine. Spontaneous
EBRs predicted performance in divergent thinking, a sub-
component of creativity that has been associated with
enhanced dopaminergic functioning (Ashby et al. 1999;
Eysenck 1993). Interestingly for our purposes, the rela-
tionship followed an inverted U-shaped function with
average EBRs producing better performance than low or
high EBRs. Also of interest, a behavioral genetics study
has found a link between divergent thinking and the
DRD2 TAQ IA polymorphism (Reuter et al. 2006). This
polymorphism aVects the density of DA-D2 receptors; the
very receptor family that is impaired in cocaine users
who, as pointed out above, perform poorly on inhibition
tasks (Colzato et al. 2007a, b).
These encouraging observations aside, the hypothesis of
an inverted U-shaped function between SSRT and DA lev-
els certainly requires more direct investigation using diVer-
ent paradigms, such as psychopharmacological studies, but
it seems essential that individual baseline levels of DA are
taken into account. Indeed, as pointed out by Cools et al.
(2001) and Akbari Chermahini and Hommel (2009), diVer-
ent individuals are likely to have diVerent baseline levels of
DA (be it through genetic variation, drug abuse, or other
factors) and may therefore exhibit diVerential sensitivity to
the positive and negative eVects of dopaminergic drugs and
manipulations.
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